Carl Zeiss Meditec reaffirms its annual target

15-Aug-2013 - Germany

Facing a slight downturn in the overall market, Medical technology provider Carl Zeiss Meditec AG raised its revenue by 2.9 percent to EUR 649 million (previous year: EUR 630.8 million) in the first nine months of financial year 2011/2012. In the first nine months of the current financial year, the Company increased its earnings before interest and taxes (EBIT) from EUR 88.6 million to EUR 92.5 million and confirms its revenue forecast for the whole year.

"Thanks to our balanced global presence we achieved once again a solid result despite disparate development in the strategic business units and we consider ourselves to be well on the way for achieving our goals in the current financial year", says Dr. Ludwin Monz, President and CEO of Carl Zeiss Meditec AG. The Company is predicting sales totaling between EUR 880 and 910 million in the current financial year 2012/2013.

Other news from the department business & finance

Most read news

More news from our other portals

Is artificial intelligence revolutionizing the life sciences?